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Abstract
We have previously shown that experimental infection caused by Trypanosoma cruzi is associated with changes in the
hypothalamus-pituitary-adrenal axis. Increased glucocorticoid (GC) levels are believed to be protective against the effects of
acute stress during infection but result in depletion of CD4+CD8+ thymocytes by apoptosis, driving to thymic atrophy.
However, very few data are available concerning prolactin (PRL), another stress-related hormone, which seems to be
decreased during T. cruzi infection. Considering the immunomodulatory role of PRL upon the effects caused by GC, we
investigated if intrathymic cross-talk between GC and PRL receptors (GR and PRLR, respectively) might influence T. cruzi-
induced thymic atrophy. Using an acute experimental model, we observed changes in GR/PRLR cross-activation related with
the survival of CD4+CD8+ thymocytes during infection. These alterations were closely related with systemic changes,
characterized by a stress hormone imbalance, with progressive GC augmentation simultaneously to PRL reduction. The
intrathymic hormone circuitry exhibited an inverse modulation that seemed to counteract the GC-related systemic
deleterious effects. During infection, adrenalectomy protected the thymus from the increase in apoptosis ratio without
changing PRL levels, whereas an additional inhibition of circulating PRL accelerated the thymic atrophy and led to an
increase in corticosterone systemic levels. These results demonstrate that the PRL impairment during infection is not caused
by the increase of corticosterone levels, but the opposite seems to occur. Accordingly, metoclopramide (MET)-induced
enhancement of PRL secretion protected thymic atrophy in acutely infected animals as well as the abnormal export of
immature and potentially autoreactive CD4+CD8+ thymocytes to the periphery. In conclusion, our findings clearly show that
Trypanosoma cruzi subverts mouse thymus homeostasis by altering intrathymic and systemic stress-related endocrine
circuitries with major consequences upon the normal process of intrathymic T cell development.
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Introduction
The thymus is a primary lymphoid organ in which bone
marrow-derived T cells differentiate into mature T lymphocytes.
Thymus homeostasis is disrupted in several infectious diseases,
including acute infection by Trypanosoma cruzi, the causative agent
of Chagas disease [1,2]. Accordingly, T. cruzi acutely-infected mice
exhibit an intense thymic atrophy mainly characterized by a
massive loss of cortical CD4+CD8+ thymocytes and an aberrant
output of immature T cells, which have likely bypassed the
negative selection process and may be involved with the
generation of T cell autoimmune events seen in both murine
and human Chagas disease [3–5].
It is well known that both prolactin (PRL) and glucocorticoid
(GC) receptors (PRLR and GR, respectively) are constitutively
expressed in thymocytes [6,7], and their activation is related to
the control of many aspects of thymus physiology. Besides
participating in intrathymic T cell selection events, GCs inhibit
thymocyte proliferation and induce apoptosis of these cells, acting
via a specific receptor, inducing cell death through a caspase
activation pathway [8–11]. On the other hand, PRL stimulates
intrathymic T-cell proliferation and inhibits GC-induced thymo-
cyte apoptosis [12,13]. A further important issue concerning
thymic homeostasis and stress hormones is the fact that, in
addition to the endocrine function of GCs and PRL upon
thymocytes and thymic microenvironmental cells, both hormones
are produced intrathymically, and likely act locally through
autocrine and/or paracrine loops [7,14,15].
The precise mechanisms triggering thymic involution following
T. cruzi infection are not completely elucidated but seem to be, at
least partially related to the rise of GCs systemic levels, a well-
known effect comprised within the complex stress response to
acute infections [1,16]. Interestingly, in addition to increasing
systemic GCs levels, infection affects PRL contents, another stress
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hormone that seems to counteract certain GC effects in the
immune system [17,18]. During T. cruzi infection, although the
increased circulating levels of GCs can be protective by impeding
an exacerbated production of pro-inflammatory cytokines (which
might drive infection to a lethal course), they also induce
deleterious effects upon thymus, particularly by triggering
apoptosis of developing thymocytes [19]. Accordingly, adrenalec-
tomy plus inhibition of GR by the RU-486 compound significantly
prevented T. cruzi-induced cortical thymocyte depletion [1].
Nevertheless whether or not this is only a systemic endocrine
effect or also comprises the paracrine role of intrathymically
produced GCs, has not been determined.
Few data are known concerning the effects of PRL during T. cruzi
infection. Yet, it has recently been showed that PRL supplemen-
tation in infected rats is associated with an improvement of the
immune response [20]. However, a possible role of PRL (either via
endocrine and/or paracrine pathways) in preventing thymic atrophy
and the exit of potentially autoreactive T cells remains elusive.
Considering the immunomodulatory role of PRL upon the
thymus and the effects caused by GCs, we investigated herein the
role of PRL during thymic atrophy and whether intrathymic cross-
talk between PRL/GC-mediated circuitries might influence the
outcome of the T. cruzi-induced thymus atrophy. Here we showed
that T. cruzi infection subverts the host’s endocrine system inducing
an abnormally high response of GCs in detriment of PRL signaling
to immature CD4+CD8+ thymocytes, consequently leading to a
thymic atrophy outcome. Accordingly, both thymocyte apoptosis
and the abnormal appearance of CD4+CD8+ cells in peripheral
lymphoid organs could be significantly prevented in animals treated
with drugs that stimulate PRL synthesis.
Results
The onset of thymic atrophy is associated to an
imbalance of GR and PRLR gene expression
Several research groups have demonstrated that acute T. cruzi
infection in mice courses with a progressive thymic atrophy caused
mainly by the depletion of immature CD4+CD8+ thymocytes
[1,17,21]. Previously we reported that the onset of CD4+CD8+ cell
loss occurs after 8 days post-infection (dpi), and is characterized
by the increase in the percentage of apoptosis [17]. After 15 dpi,
the thymus was highly atrophic, with a reduction of 80% in the
numbers of CD4+CD8+ thymocytes.
Based on these data we analyzed the expression of the genes
coding for GRa and long form of PRLR in CD4+CD8+
thymocytes from infected mice. We found that these cells
progressively reduced GR gene expression during infection,
presenting a six-fold decrease after 15 dpi. At the same time, the
expression of the PRLR gene increased continuously in this same
subset (Fig. 1A, left panel). As result, CD4+CD8+ cells exhibit a
progressive diminution of GR/PRLR expression ratio during
infection (Fig. 1A, right panel). The decrease in GR and increase
in PRLR gene expression seems to render these remaining cells
less sensitive to GC effects. Accordingly, CD4+CD8+ thymocytes,
freshly isolated from infected mice, progressively exhibited a
lower apoptosis ratio after being challenged with dexamethasone
in vitro, compared to the apoptosis triggered when the vehicle
alone was applied (Table S1, Fig. 1B left and right panels). By
contrast, when these cells were incubated with prolactin, no
changes were detected in the apoptosis ratio (data not shown).
CD4+CD8+ thymocyte depletion during acute T. cruzi
infection is associated with systemic and intrathymic
PRL-GC hormonal imbalances
As stated above, PRL and GCs are stress-related hormones,
while PRL seems to counteract the GCs-induced thymocyte
apoptosis [12,13]. As previously demonstrated, during T. cruzi
infection PRL levels progressively decreased concomitant to a GC
rise in the sera of infected mice (Fig. S1). This hormonal imbalance
clearly paralleled the progression of CD4+CD8+ cortical thymo-
cytes depletion [17].
In order to better understand the stress-related hormonal
circuits in the context of disruption of thymus homeostasis due to
T. cruzi infection, we studied the intrathymic expression of both
hormones. Infected thymuses exhibited a decrease in the local
production of corticosterone after 8 dpi, which was reestablished
to uninfected levels after 15 dpi (Fig. 2A). This intrathymic GC
fluctuation was related with changes in the 11b-HSD2/11b-HSD1
balance. Compared to controls, the highest levels of 11b-HSD2
gene expression were observed after 8 dpi, while for 11b-HSD1
was observed after 15 dpi. Therefore, increased 11b-HSD2 gene
expression at 8 dpi supposed an increase of the active form of
the enzyme and could explain the diminution in the thymic
contents of corticosterone at the same day, whereas the increased
expression of 11b-HSD1 after 15 dpi. overcomes these effects
increasing corticosterone levels. (Fig. 2B).
The intrathymic PRL production was also altered during T. cruzi
infection. PRL was augmented in thymuses from 8 dpi mice
(Fig. 2C). Immunofluorescence analyses indicate that medullary
thymic epithelial cells are the main intrathymic source of PRL
during acute infection (Fig. 2D). Morphometric evaluation showed
that PRL was augmented in the thymic medulla in both 8 and
15 dpi thymuses, and a significant increase in the cortex was
observed after 8 dpi (Fig. 2E), with a trend to diminish after 15 dpi.
The opposing systemic versus thymic modulation of PRL
levels during T. cruzi infection suggests that each circuitry acts
independent to each other, in response to the parasite infection.
To investigate this issue, thymuses and blood were collected
simultaneously from infected mice treated with bromocriptine
(BRC), a potent D2 agonist that inhibits the release of pituitary
PRL, or vehicle applied as negative control. As expected, BRC
Author Summary
It is currently estimated that 90 million people in America
are exposed to T. cruzi infection, the causative agent of
Chagas disease. Despite the mortality and morbidity, this
infection is yet considered a neglected disease, due to the
lack of effective, safe, and affordable pharmaceuticals for
controlling it. T. cruzi leads to immunosuppression of the T
cell compartment and to chronic cardiac inflammation,
which seems to be associated with the disruption of
thymic homeostasis. Thymus atrophy, characteristic of
acute infection, is mainly associated with the loss of
immature CD4+CD8+ thymocytes, which in turn is associ-
ated with increased corticosterone systemic levels, togeth-
er with their premature export to the periphery as
potential autorreactive cells. Although being deleterious
to the thymus, GCs are protective during this infection, for
avoiding an exacerbated pro-inflammatory response. Here
we demonstrate that the increase of GCs in plasma is
related to the impairment of PRL systemic levels. The
intrathymic hormonal circuitry is also altered during
infection and an imbalance of the cross-talk involving GR
and PRL is related with CD4+CD8+ depletion. The partial
restoration of PRL levels prevented thymus atrophy of
infected mice, thus partially reverting the T. cruzi-induced
subversion of the organ, ultimately reestablishing thymus
homeostasis.
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generated a drastic decrease of systemic PRL levels in uninfected
mouse (Fig. 2F). Nevertheless, this treatment increased the
intrathymic contents of the hormone. Both systemic and
intrathymic corticosterone levels remained unchanged in BRC-
treated mice (Fig. 2F).
Systemic PRL impairment in T. cruzi infected animals
causes an increase of GC levels, which impact upon the
thymic atrophy
We have previously identified that GCs are potent stimulators of
immature thymocyte loss during T. cruzi infection. Nevertheless,
nothing was known concerning the role of PRL upon the systemic
increase of GCs during infection, nor the possible impact upon
thymus atrophy. In order to clarify this issue, mice were treated
daily with BRC, from the moment of infection until 15 dpi, when
they were sacrificed and their blood and thymus analyzed.
Infected animals treated with BRC presented an increase in
systemic GC levels of approximately fourfold, and this was
associated with decreased thymocyte numbers, when compared to
the mice that only received PBS (Fig. 3A), as well as an increased
parasitemia [parasites/mL, median (rank), n = 5mice/group;
15 dpi.: BRC group: 9000 (8000–12000), PBS group: 6000
Figure 1. Trypanosoma cruzi induces changes in gene expression of glucocorticoid and prolactin receptors in CD4+CD8+ cells and
alters their sensitivity to GC-induced apoptosis. Panel A (left) shows gene expression levels for the receptors for glucocorticoids (GR) and
prolactin (PRLR) in CD4+CD8+ thymocytes, as ascertained by real time quantitative PCR. There is a progressive decrease in GR expression levels during
T. cruzi infection, which were paralleled by an increase in PRLR gene expression. The values were normalized to the endogenous reference transcript
RPL-13. Values are expressed as fold changes related to uninfected animals and represented as (22DDct). Panel A (right) represents the ratio of GR/
PRLR in CD4+CD8+ thymocytes during infection. These data are representative of three independent experiments using three mice per group in each
experiment. Statistically significant differences (p,0.05) between uninfected versus infected (*) or between 8 and 15 dpi (#) mice. Panel B (left)
depicts progressive increase in apoptosis (revealed by the relative numbers of Annexin V+CD4+CD8+ cells). We can see that in cells treated with
vehicle alone or after inbubation with dexamethasone (DEX) there is an increase in the numbers of apoptotic thymocytes. However, if we evaluate
the ratio of vehicle-treated over DEX-treated cells (panel B right) the sensitivity to DEX-induced apoptosis on CD4+CD8+ thymocytes is significantly
decreased as disease progresses. Thymyses were removed from uninfected, 8 and 15 dpi mice and homogenized. One million cells/animal were
incubated with DEX (1029 M) or RPMI (vehicle) during 8 hours under 37uC at 5% CO2 atmosphere. Thymocytes were then washed and incubated with
anti-CD4/APC, anti-CD8/PercP or Annexin-V/FITC, for the cytofluorometric characterization of apoptosis within each thymocyte subset. These data are
representative of two independent experiments using five mice per group in each experiment. Statistically significant differences (p,0.05) between
uninfected versus infected (*) or between 8 and 15 dpi (#) mice. *p,0.05; **p,0.01, ***p,0.001.
doi:10.1371/journal.pntd.0002470.g001
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Figure 2. The intrathymic production of glucocorticoids and prolactin is differentially modulated by T. cruzi infection. Panel A reveals
the transient decrease of GC production whereas panel B shows the differential gene expression levels of the enzymes 11b-HSD1 and 11b-HSD2. In
parallel with the transient decline in GC production, there is a transient increase in prolactin contents as shown in panel C. Intrathymic in situ
prolactin labeling is seen in panel D, through representative confocal microscopy images of thymuses from uninfected and infected mice. In this
panel, thymuses were stained with the anti-PRL antibody, whereas the lower right box corresponds to the negative control for the immunostaining in
which the anti-PRL was replaced by an unrelated goat IgG. The quantification of fluorescence intensity, separately done in the cortex and medulla of
thymic lobules, revealed that the rise in PRL contents occured in both regions, as seen in panel E. As expected, bromocriptine (BRC), as an inhibitor of
prolactin secretion by the anterior pituitary gland, promotes a shutdown of systemic prolactin levels (compared to the treatment with the vehicle
alone), as measured in the blood (panel F left). However, injection of this compound into normal mice does not induce a decrease in the intrathymic
PRL contents, as seen in panel F, when comparing BRC- versus vehicle-treated animals. Indeed, a slight (but significant) increase of PRL in the thymus
could be detected in BRC-treated animals. Both intrathymic and systemic corticosterone levels remained unchanged in these animals (panel F, right).
The intrathymic levels of corticosterone were determined by radioimmunoassay, whereas prolactin contents were measured by ELISA in thymus
lysates from normal and infected (8 and 15 dpi) mice. In both cases, results were expressed as pg/mg thymus. The transcript levels of 11b-HSD1 and
Trypanosoma cruzi Disrupts Thymic Homeostasis
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(4000–7000), p,0.05]. Interestingly, a significantly enhancement
in GC levels was only observed in infected animals treated with
BRC, but not in the uninfected counterparts, thus revealing that
this phenomenon resulted as a consequence of T. cruzi infection. In
an attempt to check a possible cross-talk between PRL- and GC-
mediated circuits, we analyzed if the decrease of PRL secretion
during infection could be related to the GC rise. For this, we
adrenalectomized mice (ADX) one week prior to infection, in
order to remove GC systemic contents, and then analyzed the
PRL levels and thymuses of the animals. Although thymic atrophy
was prevented in ADX infected mice and parasitemia diminished
[parasites/mL (n = 5mice/day), 15 dpi: ADX group: 2500 (1000–
6000), Sham group: 8000 (5000–10000)], p,0.05)], circulating
PRL levels remained decreased in both Sham and ADX animals
(Fig. 3B).
Thus, it seems that although in infected mice PRL diminution
acts as a permissive factor to the increase in GC synthesis, GC are
not related, at least directly, to the diminished PRL systemic levels.
The re-establishment of systemic PRL by metaclopramide
limits T. cruzi-induced thymic atrophy
Since PRL seems to protect from GC-induced thymic atrophy
during acute infection, together with the fact that its depletion
worsened the course of disease, we decided to evaluate the effect of
PRL re-establishment in T. cruzi-infected mice. Animals were daily
given metaclopramide (MET) from the day 10 until 14 dpi and
then killed. MET administration not only was able to increase
PRL systemic levels (Fig. 4A), but also diminished the thymus
atrophy (Figs. 4B–C). Interestingly, MET treatment did not induce
obvious alterations in GC levels, which remained increased in
infected MET-treated mice at the same levels that were seen in the
infected PBS-treated mice (Fig. 4A). As expected, MET admin-
istration diminished systemic GC/PRL ratio in both uninfected
and infected mice (expressed as % of expression change of MET in
respect to PBS-treated mice (ie. GC/PRL ratio uninfected = 0.4;
Infected-15 dpi = 0.6) Nevertheless, increase in PRL levels did not
influence the control of infection [parasites/mL (n= 5mice/day),
Infected-15 dpi: MET group: 4500 (3000–7000); PBS group: 5500
(2800–7000), p.0.05] but prevented the loss of CD4+CD8+
thymocytes in infected mice (Fig. 4D) The degree of apoptosis
(Fig. 4E) and also the proportion of cells showing caspase-3 activity
were also decreased in these cells, strongly indicating that PRL
prevents CD4+CD8+ apoptosis by inhibiting activation of caspase-
3 pathway (Fig. 4F).
Surprisingly, MET administration induced the augment of
intrathymic corticosterone and impaired PRL contents in infected
mice, which presented a large increase of intrathymic GC/PRL
level ratio (expressed as % of expression change of MET in respect
to PBS-treated mice (ie. GC/PRL ratio, uninfected = 2.5;
15 dpi = 50).
As mentioned above, one of the outcomes of the T. cruzi-
induced disruption of thymus homeostasis is an abnormal release
of immature CD4+CD8+ to the periphery of the immune system
(4, 5). We thus investigated if MET administration in infected
animals could also modulate this event. Indeed, we found that
MET significantly diminished the absolute numbers of
CD4+CD8+ T cells in subcutaneous lymph nodes of infected mice
(Fig. 5). Together, these data demonstrate that decreased PRL
directly affects thymocyte viability and leads to the thymus atrophy
outcome during acute T. cruzi infection.
Discussion
The host defense mechanisms, during experimental Chagas
disease seem to be under thymic control. Congenitally athymic
homozygous (nu/nu) mice were shown to be significantly more
susceptible to T. cruzi infection than their thymus-bearing
heterozygous (nu/+) [21]. Moreover, adult thymectomy increased
chagasic myocarditis [22].
We have previously shown that thymic atrophy during acute
experimental Chagas disease is characterized by a massive loss of
CD4+CD8+ thymocytes, being related to the pro-apoptotic action
of increased levels of circulating GCs [1,19]. Such depletion is
associated with a systemic immunoendocrine imbalance, in which
GCs and TNF-a are involved [19,23]. The precise mechanisms
underlying this phenomenon are not completely elucidated, but
they are likely linked to a particular pathogen-host relationship
established during infection. Moreover other hormones could be
involved in this altered response. Here we analyzed the
involvement of PRL in these abnormalities.
It is well known that PRL and GCs are stress hormones, which
systemic levels are increased during adverse stimuli [24,25]. Under
these conditions, increased PRL could protect the host from an
exacerbated immunosuppressive response mediated by GCs.
Nevertheless, during murine T. cruzi infection this balance seems
to be disrupted, since we observed a progressive decrease of
systemic PRL paralleling the enhancement of GCs, as previously
demonstrated [17]. This hormone imbalance was already signif-
icant at 8 dpi, when we detected the onset of thymus atrophy,
which increased along with disease progression. It is known that
PRL and GCs participate in many aspects of thymus physiology,
presenting opposite activities, which ultimately contribute to the
maintenance of the organ homeostasis [7,14]. CD4+CD8+
thymocytes from infected mice presented reduction of GR-a
transcript simultaneously to an increase in the long form PRLR
gene expression. This GR-a is generated through an alternative
use of exon 9b, and is highly related to the immunosuppressive
properties of GCs [26,27]. On the other hand, the signaling
generated by long form of the PRLR, the main isoform presented
in the thymus [28], is strongly associated with biological activities
related to the Stat5-P transcriptional activities, which include the
prevention of GC-induced apoptosis in T cells [29]. This inverse
regulation of GR/PRLR might be a consequence of alteration of
GC/PRL ratio. Previous findings have pointed that increased
levels of GCs down-modulate GR and up-regulate PRLR [30–32].
CD4+CD8+ thymocytes that remained at 15 dpi presented a lower
sensitivity to GCs-induced apoptosis associated both to GR and
PRLR modulation, suggesting these receptors may interact
influencing CD4+CD8+ viability. It seems that the changes in
GR/PRLR ratio are related to an intrinsic ability of these cells to
11b-HSD2 genes were ascertained by quantitative real time PCR. The results represent the amount of transcripts, in relation to the housekeeping
gene RPL-13 as 22Dct. As for the confocal microscopy, the original magnification was6200, with the scale bars = 20 mm. Graphs in panel E correspond
to quantification of PRL contents, defined by immunofluorescence in 5 microscopic fields of each thymus from uninfected (n = 3) or infected animals
(n = 3), with data being represented as pixels/mm2. Male mice were daily given s.c. BRC (100 mg/animal) during three days, when they were sacrificed
and their thymuses and plasma obtained. Intrathymic and plasma PRL contents were measured by ELISA, with data being expressed as ng/mL in sera,
and as pg/mg in the thymus. Statistically significant differences (p,0.05) between uninfected versus infected (*) or between 8 and 15 dpi (#) mice.
*p,0.05; **p,0.01, ***p,0.001.
doi:10.1371/journal.pntd.0002470.g002
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Figure 3. CD4+CD8+ depletion in T. cruzi infected animals is related to the increased systemic GC levels, subsequent to decrease in
serum PRL. In panel A, the effects of the PRL synthesis inhibitor, bromocriptine (BRC) is shown, whereas the effects of adrenalectomy (thus
abrogating adrenal-derived GCs) are seen in panel B. BRC-induced shutdown of pituitary PRL production increases serum GC levels, but
adrenalectomy does not promote a reciprocal rise in PRL. Moreover, BRC decreases thymocyte numbers in infected animals, whereas ADX promote a
significant increase in the total numbers of these cells. Infected and uninfected animals were daily given BRC (10 mg/kg/100 ml s.c.) or vehicle alone
for 15 days, when they were killed under non-stressor conditions. Mice were adrenalectomized one week prior to infection, and sham surgery was
performed in control animals. Sera were used for quantifying PRL (by ELISA) and corticosterone (by radioimmunoassay). Simultaneously, thymuses
were removed and total thymocyte numbers determined. Data are representative of two independent experiments using five to eight mice per
group in each experiment. Statistically significant differences (p,0.05) between uninfected versus infected (*) or between 8 and 15 dpi (#) mice.
*p,0.05; **p,0.01, ***p,0.001.
doi:10.1371/journal.pntd.0002470.g003
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be protected against the pro-apoptotic action of increased systemic
GCs during T. cruzi infection.
Although pro-inflammatory cytokines released during infection
have been identified as potent stimulators of GC synthesis by the
adrenal gland [1,33], nothing is known on the role of PRL upon
the systemic GC rise seen in experimental Chagas disease. The
pharmacological blockage of PRL synthesis during the whole
course of infection caused an additional increase of circulating
corticosterone and a more severe thymus atrophy, when compared
to infected animals that received vehicle alone. This data suggest
that the systemic PRL production is necessary to control the
secretion of GCs and their effects upon the thymus during T. cruzi
infection. However, we did not detect any alteration of PRL
levels in infected mice lacking circulating GCs. Which factor(s)
determine the decrease of PRL secretion during infection
remain(s) unknown. It is possible that pro-inflammatory cytokines
systemically available alter hypothalamic circuits. In keeping
with this possibility, both IL-6 and IL-1b have been described to
inhibit PRL secretion by the anterior pituitary [34]. MET
administration, which inhibits dopaminergic receptors located in
the hypothalamus, did recover PRL systemic levels, showing that
the control mechanisms of PRL secretion by the pituitary gland
are preserved during infection. Thus, although the adenopituitary
function seems to be impaired during T. cruzi infection [35], the
pituitary synthesis of PRL can be restored in infected individuals
through the use of PRL secretagogues.
The systemic scenario seems to differ from the one observed
intrathymically. Our results reveal that the onset of the thymic
atrophy, in the early phase of acute infection (8 dpi), occurs in
parallel with the modulation of intrathymic contents of both
PRL and GCs. However, contrasting to what was observed in
the serum, there was a local PRL increase together with an
impairment of corticosterone production, suggesting that the
intrathymic synthesis of these hormones does not depend on the
systemic circuitry It is known that the availability of corticosterone
in thymus is related with a local 11b-HSD2/11b-HSD1 balance.
Figure 5. Metaclopramide diminishes the abnormal appearance of CD4+CD8+ cells in subcutaneous lymph nodes from T. cruzi
infected mice. The figure shows that in mice treated with the vehicle alone, acute T. cruzi infection did induce the abnormal appearance of
CD4+CD8+ cells in subcutaneous lymph nodes (SCLN). Although such cells were also detected after in vivo treatment metoclopramide (MET, which
promotes an increase in circulating PRL levels) their absolute numbers were significantly lower than those recorded in infected counterparts treated
with the vehicle alone. Uninfected and infected mice received daily s.c. MET from 10 to 14 dpi or PBS as vehicle. At 15 dpi they were killed and their
SCLN removed, homogenized and counted using Neubauer chamber. One million viable cells were immunostained with anti-CD4, anti-CD8 and anti-
TCRb antibodies, and CD4+CD8+ T cells were thus characterized. Absolute numbers of these CD4+CD8+ T cells were expressed as mean 6 SE. These
data are representative of two independent experiments using three mice per group in each experiment. Statistically significant differences (p,0.05)
between uninfected versus infected (*) or between 8 and 15 dpi (#) mice. ***p,0.001.
doi:10.1371/journal.pntd.0002470.g005
Figure 4. The metoclopramide-induced reestablishment of PRL synthesis in infected mice prevents thymus atrophy. As shown in
panel A, metoclopramide (MET) does increase PRL serum levels, but without affecting the T. cruzi-induced rise in serum corticosterone. Yet, as
observed in B the CD4+CD8+ thymocyte subset profiles were partially reestablished in MET-treated infected animals, and so was the size of their
thymuses (representative images seen in panel C; scale bar = 1 cm). Thymic recovery was further confirmed by the partial yet significant restoration of
total thymocyte numbers as well as absolute numbers of CD4+CD8+ cells (D). MET also reduced the percentages of apoptotic CD4+CD8+ thymocytes,
including those exhibiting activated caspase-3 (E and F, respectively). Intrathymic levels of corticosterone were increased in MET-treated mice
whereas PRL decreased, as demonstrated in G. Uninfected and infected mice received daily MET (2.5 mg/kg/100 ml, s.c.) from 10 to 14 dpi, or PBS as
negative control. On 15 dpi, animals were sacrificed and their thymuses and sera removed for analysis. Cytofluorometric profiles for detection of CD4
and CD8 are shown as dot blots (panel B) with inserted numbers corresponding to percentages of CD4+CD8+ subset as mean 6 SE. CD4+CD8+
apoptotic cells were characterized as AnnexinV-FITC positive staining, whereas the activity of caspase-3 was ascertained as FITC-VAD-FMK positive
cells. The values are given as percentage of CD4+CD8+ cells with active caspase-3. In all cases, data are representative of two independent
experiments using five mice per group. Corticosterone and PRL levels were determined, respectively by radioimmunoassay and ELISA. Intrathymic
contents are represented as pg/mg thymus and systemic levels as ng/mL. Statistically significant differences (p,0.05) between uninfected versus
15 dpi (#) mice. *p,0.05; **p,0.01, ***p,0.001.
doi:10.1371/journal.pntd.0002470.g004
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While 11b-HSD2 mainly catalyzes the conversion of biologically
active corticosterone in its inactive derivative 11-dehydrocorticos-
terone, 11b-HSD1 acts in the opposite way, determining the
local contents and the availability of GCs. However, the precise
mechanisms involved in the intrathymic synthesis of PRL are
not elucidated. It seems that extrapituitary cells secrete PRL by
pit-1-independent mechanisms [36]. Moreover, systemic and
intrathymic regulation events are independent, favoring the idea
of separate endocrine niches inside the thymus. The precise
involvement of locally produced hormones for thymus atrophy is
not clear, but we can conceive that the inverse modulation related
to systemic levels that occurs at the initial phase of atrophy
corresponds to compensatory intrathymic events so that to restore
the organ homeostasis, similar to what has been reported for local
production of hormones in different organs [37,38].
In the last set of experiments, we checked if the reestablishment
of PRL systemic levels could prevent T. cruzi-induced thymic
atrophy. The administration of MET in later acute infection,
increased circulating PRL and restored thymus cellularity,
diminishing the loss of CD4+CD8+ by apoptosis, inhibiting the
activation of caspase-3. Interestingly, the short period of MET
administration prevented thymus atrophy without altering para-
sitemia or systemic GC levels, thus indicating a direct effect of
PRL upon thymocyte survival.
It should be pointed out that we only achieved our results
working with a low dose of MET, able to reestablish circulating
PRL of infected mice to levels quite similar to uninfected mice.
This is in keeping with the data reported by Tomio and co-
workers, showing that only low doses of PRL are able to activate
PRLR on T cells, whereas higher doses rather suppress this
response [39].
Together, our results indicate that PRL counteracts GC
effects in situations of increased GCs, by a cross-talk action
directly affecting GR signaling in CD4+CD8+ cells. As previously
mentioned, PRL suppresses many GR transcriptional activities by
the induction of Stat5-P, a transcriptional factor related with the
PRLR/JAK pathway [40]. In this way, it has been described that
PRL protects thymocytes from GCs-induced apoptosis both in vitro
as in vivo, by the induction of anti-apoptotic proteins, like bcl-2 and
XIAP, which inhibit caspase activation [12,13].
Importantly, reestablishing systemic PRL through MET stim-
ulation not only prevented thymic atrophy, but also significantly
decreased the numbers of CD4+CD8+ cells in the periphery of
the immune system, as ascertained in subcutaneous lymph nodes
of infected mice. Since these activated and potentially autoreactive
cells are abnormally released from atrophic thymuses [3–5], it is
conceivable that PRL-mediated thymus protection also influences
in the abnormal export of these immature T cells.
In conclusion, our findings clearly show that Trypanosoma
cruzi subverts mouse thymus homeostasis by altering intrathymic
and systemic stress-related endocrine circuitries with major
consequences upon the normal process of intrathymic T cell
development, as schematically illustrated in figure 6. Moreover,
exogenously induced enhancement of prolactin secretion partially
Figure 6. Representative scheme illustrating how T. cruzi infection possibly alters the endocrine status resulting in thymus atrophy.
Trypanosoma cruzi infection impairs PRL synthesis by the anterior pituitary and increases corticosterone release by the adrenal. The decrease of
circulating PRL seems to directly affect corticosterone synthesis, inducing its increase in circulation. This hormonal imbalance affects intrathymic
homeostasis, increasing locally produced PRL simultaneously to the decrease of intrathymic GC contents. Simultaneously, GR progressively
diminishes at CD4+CD8+ while PRLR increases. The alteration in the expression levels of both receptors seems to be associated with the increasing
sensitivity to apoptosis showed by the CD4+CD8+ thymocyte subset. Additionally, systemic variations of PRL levels promote the occurrence of
potentially autoreactive CD4+CD8+ cells in periphery, phenomena clearly observed during acute and chronic T. cruzi infection.
doi:10.1371/journal.pntd.0002470.g006
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restores normal thymocyte development, reducing the apoptosis
of these cells by inhibiting the pro-apoptotic action of GCs, as well
as the numbers of immature CD4+CD8+ T cells in the periphery
of the immune system.
As final consideration, evidence showed here supports the
notion that the immune and the neuroendocrine systems act in
coordinating a defensive response during infectious processes.
Nevertheless, these protective mechanisms may create an adverse
state that affects thymic homeostasis. The possible causes for the
observed T. cruzi infection-associated endocrine disturbances
include several and not mutually exclusive possibilities. Immune
derived cytokines can directly act at the hypothalamus-pituitary
level and/or upon peripheral glands, such as the adrenals.
Moreover, in situ inflammatory reactions promoted by the parasite
or their antigens in the endocrine microenvironment may lead to a
transient immuno-endocrine dysfunction.
Materials and Methods
Ethics statement
This study was approved by the Animal Research Ethics
Committee of the Oswaldo Cruz Foundation, Rio de Janeiro
(protocol CEUA-0145-02) and the Bioethics and Biosecurity
Committees of Faculty of Medical Sciences from National
University of Rosario (Resolution Nu3913/2009). All animal
experimentation was performed in accordance with the terms of
the Argentine and Brazilian guidelines for the animal welfare
regulations in accordance with international guidelines.
Animals, drug treatment and infection
Male BALB/c mice, aging 6–8 weeks, were obtained from the
animal facilities of the Oswaldo Cruz Foundation (Rio de Janeiro,
Brazil) and the National University of Rosario (Rosario, Brazil).
Tulahue´n strain was maintained by serial passages in the Vero
cell line. Mice were infected subcutaneously with 100 viable
trypomastigotes, counted using Neubauer chambers. To monitor
the systemic repercussion of the acute disease, parasitemia and
analysis of lymphoid organs were recorded following infection,
where parasitemia was evaluated using the Brener method, as
previously reported [1]. In order to modulate the intrapituitary
synthesis of PRL, bromocriptine (BRC) and metoclopramide
(MET), D2-dopaminergic agonist and antagonist, respectively,
were administrated subcutaneously (s.c.) in uninfected and infected
mice. Drugs were obtained from Sigma-Aldrich (St. Louis, EUA).
BRC was dissolved in ethanol:saline 0.9% (2:8) and daily
administered at the concentration of 10 mg/kg/100 ml during
the whole infection period. MET was diluted in PBS and
administrated from 10 to 14 dpi, at a final concentration of
2.5 mg/kg/100 ml. In each condition, a group of animals was
inoculated with the respective vehicle as control.
Adrenalectomy
Mice were anesthetized with 100 mg/kg ketamine and 2 mg/kg
xylazine and bilateral adrenalectomy was performed via a dorsal
surgical approach. Two small incisions were made on each side
of the back just below the rib cage and the adrenal glands were
removed with curved forceps. Sham mice were operated in a
similar manner, but without removing the adrenals. The animals
were used for further experimentation 1 week after the surgery.
Determination of systemic levels of corticosterone and
prolactin
Mice were housed individually for 1 week before the
experiments were started and kept single-caged throughout the
experiments in temperature-, humidity-, and light (12 h light: 12 h
darkness cycles)-controlled rooms. Samples for hormone determi-
nations were obtained by tail bleeding between 08.00 and 10.00
a.m., after 8 and 15 dpi, as well as from uninfected mice. Blood
was centrifuged during 10 min at 1,500 rpm at 25uC and serum
was stored frozen at 220uC until analyzed. Corticosterone
levels were determined by RIA (MP Biomedicals, New York,
USA) as previously described [41], whereas PRL concentration
was evaluated by specific ELISA kit, according to the manufac-
turer’s specifications (R&D Systems, Minneapolis, USA).
Determination of intrathymic hormone contents
Simultaneously to blood collection, thymuses were removed,
weighted and homogenized in PBS with protease inhibitors
cocktail (Hoffmann-La Roche Ltd, Switzerland). After centrifuga-
tion at 12,000 rpm at 4uC, during 10 min, supernatants were
kept at 280uC until used. Prolactin and corticosterone levels were
determined as described above. Final hormone concentrations
were represented by the ratio of hormone concentration in
supernatants and thymus weight.
In situ detection of prolactin and GC in the thymus
The pattern of intrathymic PRL localization was ascertained by
indirect immunofluorescence assay. Thymuses were removed from
uninfected mice and after 8 and 15days of infection, embedded
in Tissue-Tek (Miles, Elkhart, USA) and frozen in liquid nitrogen.
Five mm-thick cryostat sections were settled on poly-L-lysine
(Sigma, Missouri, USA) covered glass slides, acetone fixed and
incubated with PBS-BSA 1% to avoid nonspecific binding of
fluorochromes. Samples were submitted to specific goat anti-
mouse prolactin polyclonal antibody (Santa Cruz Biotechnology,
California, USA), 1:50 for 1 hour at room temperature, washed
and submitted to appropriate secondary antibody, 1:500 Alexa
488-coupled goat anti-rabbit IgG (Molecular Probes, Eugene,
USA). Negative control was obtained by substituting primary
antibodies by an unrelated goat IgG. Samples were analyzed by
confocal microscopy using a LSM 510 Zeiss device (Germany) and
the images obtained were subsequently analyzed using the Image J
software (Bethesda, Maryland, USA).
Cytofluorometry and enrichment of CD4+CD8+
thymocytes
Thymuses were removed, homogenized, washed and resus-
pended in PBS containing fetal calf serum 5% (Gibco, California,
USA). For analysis of thymocyte subsets, cells (16106 thymocytes/
animal) were resuspended in flow buffer and incubated with
specific monoclonal antibodies for 30 minutes at 4uC in the dark
(anti-CD4/APC, anti-CD8/Percp, BD Pharmingen, San Diego,
USA). CD4+CD8+ lymphocytes in lymph nodes were detected
using additional anti-TCRb/FITC, for the characterization of T
cells. Apoptotic cells were identified by means of fluorescein
isothiocyanate (FITC)-conjugated Annexin-V (BD Pharmingen,
San Diego, USA). Necrotic cells were excluded using propidium
iodide (PI). The caspase activity was detected using the caspase-3
detector FITC-VAD-FMK (CaspACE, California, USA). For
each acquisition, once the T cell gate was defined, 20,000
events were recorded. Background staining values, obtained with
fluorochrome-matched IgG isotype controls, were subtracted to
establish specific fluorescence intensity. Fluorescence was mea-
sured using an FACS Canto II flow cytometer (BD Biosciences,
California, USA) and the percentages of positive cells for each
labeling were determined using the FlowJo software (Tree Star,
Oregon, USA). For cell sorting, thymocyte subsets were FACS
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isolated from three pooled thymuses obtained from mice at 8 and
15 dpi, using a MoFlo cell sorter (Beckman Coulter, Indianopolis,
EUA). The CD4+CD8+ subset thus obtained was used for further
analysis. All cells were enriched to purity greater than 97%.
In vitro assay for thymocyte-induced apoptosis
Thymuses were removed from uninfected, 8 dpi and 15 dpi
mice and homogenized. One million cells/animal were incubated
with dexamethasone (1028 M) or RPMI (vehicle) during 8 hours
at 37uC, in a CO2 incubator. After this period, cells were washed
and subjected to the anti-CD4/APC, anti-CD8/Perc or Annexin-
V/FITC, for the cytofluorometric characterization of apoptosis
within each thymocyte subset. This assay was also performed
alternatively incubating thymocytes with prolactin (1029 M).
Drugs were obtained from Sigma-Aldrich (St. Louis, EUA) and
dissolved in RPMI.
Gene expression in CD4+CD8+ thymocytes and total
thymuses
RNA was extracted from CD4+CD8+ enriched cells (106 per
group/dpi) using a commercially available kit (RNA easy minikit,
Qiagen, Courtaboeuf, France). For total thymuses analysis, RNA
was isolated using the guanidine thiocyanate kit (Invitrogen,
California, USA) following the manufacturer’s instructions. RNA
quality and quantity were assessed using an Agilent bioanalyzer
(Caliper Technologies Corp., Massachusetts, USA). First strand
cDNA synthesis was prepared with 0.5 mg total RNA, random
hexamer primer, and SuperscriptIII reverse transcriptase (Invitro-
gen, California, USA). For qPCR we used approximately 60 ng of
cDNA from each sample and SYBR Green Master Mix 2 (Applied
Biosystems, California, USA). cDNA was amplified using specific
murine primer sequences described in Table 1. All reactions were
run on the ABI 7500 Sequence Detection System (Applied
Biosystems, California, USA). After 40 cycles of amplification,
expression of CYP11A1 (cytochrome P450, family 11, subfamily a,
polypeptide 1), STAR (steroidogenic acute regulatory protein), 11b-
HSD1 (hydroxysteroid 11-beta dehydrogenase 1), 11b-HSD2
(hydroxysteroid 11-beta dehydrogenase 2), GR-a (Nr3c1, Nuclear
receptor subfamily 3, group C, member 1) and long PRLR was
assessed by comparing the expression of each to the normalizer
RPL-13a (ribosomal protein L13A) using the Ct method as
previously described (22DCt61,000) [42], subsequent to the
following primer efficiency analysis. Each experiment was run in
triplicate with different cDNA preps from the same mice. Genebank
assessment number for each of these genes can be seen in Table 2.
Statistical analyses
Differences in quantitative measurements were assessed by the
Kruskall-Wallis non-parametric analysis of variance and Mann-
Whitney U test. Correlations were evaluated by Spaerman test
(non-parametric). Results were expressed as mean 6 standard
error (SE) unless otherwise indicated. The GraphPad Instat 4.0
software (GraphPad, California, USA) was applied for statistical
analyses, and differences were considered significant when p value
was ,0.05.
Table 2. Symbols, GenBank accession numbers and descriptions of the genes mentioned in the text.
Symbol GenBank number Description
Rpl13a NM_009438.5 Ribosomal protein L13A
Prlr NM_011169.5 Prolactin receptor, transcript variant 1
GR (Nr3c1) NM_008173.3 Nuclear receptor subfamily 3, group C, member 1
Cyp11a1 NM_019779.3 Cytochrome P450, family 11, subfamily a, polypeptide 1
Cyp11b1 NM_001033229.3 Cytochrome P450, family 11, subfamily b, polypeptide 1
Star NM_011485.4 Steroidogenic acute regulatory protein
Hsd11b1 NM_008288.2 Hydroxysteroid 11-beta dehydrogenase 1
Hsd11b2 NM_008289.2 Hydroxysteroid 11-beta dehydrogenase 2
doi:10.1371/journal.pntd.0002470.t002
Table 1. Nucleotide sequences of primers used for the
analysis of transcripts and the size of the corresponding
amplicons.
Transcript
Oligonucleotide
sequence (59 to 39)
Product
size (bp)
RPL-13 180
FW CCAAGCAGGTACTTCTGGGCCGGAA
RV CAGTGCGCCAGAAAATGCGGC
GR-a (Nr3c1) 64
FW CAAGTGATTGCCGCAGTGAA
RV CATCCAGGTGTAAGTTTCTGAATCC
long PRLR 148
FW ATCATCACAGTAAATGCCACGAAC
RV GATGACAGCAGAAGAGAACGGCCAC
CYP11A1 83
FW GACCTGGAAGGACCATGCA
RV TGGGTGTACTCATCAGCTTTATTGA
STAR 69
FW TCACTTGGCTGCTCAGTATTGAC
RV GCGATAGGACCTGGTTGATGA
11b-HSD1 94
FW TGGTGCTCTTCCTGGCCTACT
RV CTGGCCCCAGTGACAATCA
11b-HSD2 79
FW CCGTGTTCTGGAAATCACCAA
RV AATATTGAGGCCAGCGTTGTTAA
doi:10.1371/journal.pntd.0002470.t001
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Supporting Information
Figure S1 Trypanosoma cruzi infection results in a
hormonal imbalance of prolactin and corticosterone
systemic levels. The graphics clearly show that circulating
corticosterone levels progressively increase along with the
infection; the opposite occurring in respect to PRL levels in the
blood. Sera were obtained from normal and infected (8 dpi and
15 dpi) and kept at 270uC until the analysis. Corticosterone levels
were determined by radioimmunoassay and prolactin by ELISA,
with the results being expressed as ng/mL. Statistically significant
differences (p,0.05) between uninfected versus infected (*) or
between 8 and 15 dpi (#) mice. **p,0.01, ***p,0.001.
(TIF)
Table S1 Dexamethasone-induced apoptosis of
CD4+CD8+ thymocytes along with T. cruzi acute infec-
tion. Thymuses were removed from uninfected (control), 8 dpi
and 15 dpi mice and homogenized. 106 cells/animal were
incubated with DEX or RPMI (vehicle) during 8 hours under
37uC at CO2 incubator. After this period cells were washed and
incubated with anti-CD4/APC, anti-CD8/Perc or Annexin-V/
FITC, for the characterization of apoptosis inside each thymocyte
subset. Values represent the ratio of CD4+CD8+ apoptotic cells.
(DOCX)
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